Spectrum and prognosis of neurologic complications after hematopoietic transplantation

Neurology

Volumn 67, Issue 11, 2006, Pages 1990-1997

  Denier, C ^a   Bourhis, J H ^b   Lacroix, C ^a   Koscielny, S ^b   Bosq, J ^b   Sigal, R ^b   Said, G ^a   Adams, D ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GANCICLOVIR; MELPHALAN; METHOTREXATE; PENICILLIN G; PENTAMIDINE; THALIDOMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROVASCULAR DISEASE; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORTICOSTEROID INDUCED MYOPATHY; EPILEPTIC STATE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC ENCEPHALOPATHY; MORTALITY; MYCOSIS; MYOPATHY; NEUROLOGICAL COMPLICATION; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; SURVIVAL; TOXOPLASMOSIS; TUMOR RECURRENCE; VIRUS ENCEPHALITIS; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33845708949     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000247038.43228.17     Document Type: Article

References (43)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-838.
2. Patchell RA, White CL, Clark AW, Beschorner WE, Santos GW. Neurological complications of bone marrow transplantation. Neurology 1985; 35:300-306.
3. Mohrmann RL, Mah V, Vinters HV. Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 1990;21:630-639.
4. Schwechheimer K, Hashemian A. Neuropathologic findings after organ transplantation: an autopsy study. Gen Diagn Pathol 1995;141:35-39.
5. Bleggi-Torres LF, de Meideros BC, Werner B, et al. Neuropathological findings after bone marrow transplantation: study of 180 cases. Bone Marrow Transplant 2000;25:301-307.
6. Graus F, Saiz A, Sierra J, et al. Neurological complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996;46:1004-1009.
7. Antonini G, Ceschin V, Morino S, et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 1998;50:1441-1445.
8. Snider S, Bashir R, Bierman P. Neurologic complications after high dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 1994;44:681-684.
9. Guerrero A, Perez-Simon JA, Gutierrez N, et al. Neurological complications after autologous stem cell transplantation. Eur Neurol 1999;41:48-50.
10. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984;16:569-576.
11. Faraci M, Lanino E, Dini G, et al. Severe neurologic complications after hematopoietic stem cell transplantation in children Neurology 2002;59:1895-1904.
12. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003;60:842-848.
13. Coplin WM, Cochran MS, Levine SR, Crawford SW. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 2001;124:1043-1051.
14. Maschke M, Dietrich U, Prumbaum M, et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999;23:1167-1176.
15. Derouin F, Gluckman E, Beauvais B. Toxoplasma infection after human allogenic BMT: clinical and serological study of 80 patients. Bone Marrow Transplant 1986;1:67-73.
16. Slavin MA, Meyers JD, Remington JS. Toxoplasmosis gondii infection in marrow transplant recipients: a twenty year experience. Bone Marrow Transplant 1994;13:549-557.
17. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Res Center, 1984-1992. Clin Infect Dis 1994;19:402-408.
18. Derouin F, Devergie A, Auber P. Toxoplasmosis in bone marrow transplant recipients: report of seven cases and review. Clin Infect Dis 1992;15:267-270.
19. Cordonnier C, Feuilhade F, Vernant JP, Marsault C, Rodet M, Rochant H. Cytomegalovirus encephalitis occurring after bone marrow transplantation. Scand J Haematol 1983;31:248-52.
20. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;330:1356-1360.
21. Mookerjee BP, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997;20:905-906.
22. Martino R, Bretagne S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation: report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000;25:1111-1114.
23. Ionita C, Wasay M, Balos L, Bakshi R. MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. Am J Neuroradiol 2004;25:270-273.
24. Johnson JD, Butcher PD, Savva D, Hollman RE. Application of the polymerase chain reaction to the diagnosis of human toxoplasmosis. J Infect 1993;26:147-158.
25. Cingolani A, De Luca A, Ammassari A, et al. PCR detection of Toxoplasma gondii DNA in CSF for differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol 1996;45:472-476.
26. Saugier-Veber P, Devergie A, Sulahian A, et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of 5 year retrospective study. Bone Marrow Transplant 1993;12:121-124.
27. Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukemia. Br J Haematol 1997;97:663-665.
28. Verweij PE, Mensik M, Rijs AJ, Donnely JP, Meis JF, Denning DW. In vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates. J Antimicrob Chemother 1998;42:389-392.
29. Lopez-Duarte M, Insunza A, Conde E, Iriondo A, Mazorra F, Zubizarreta A. Cerebral toxoplasmosis after autologous peripheral blood stem cell transplantation. Eur J Clin Microbiol Infect Dis 2003;22:548-550.
30. Fassas A, Passweg JR, Anagnostopoulos A, et al. Hematopoietic stem cell transplantation for multiple sclerosis: a retrospective multicenter study. J Neurol 2002;249:1088-1097.
31. Marmont AM, Tyndall A, Gratwohl A, Visher T. Hematopoietic precursor-cell transplants for auto-immune diseases. Lancet 1995;345:978.
32. Burt RK, Traynor A, Ramsey-Goldman R. Hematopoietic stem-cell transplantation for systemic lupus erythematous. N Engl J Med 1997;337:1777-1778.
33. Fassas A, Kimiskidis VK. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience. J Neurol Sci 2004;223:53-58.
34. Holmberg LA, Boeckh M, Hooper H, et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 1999;94:4029-4035.
35. Crippa F, Holmberg L, Carter RA, et al. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2002;8:281-289.
36. Bomberger C, Singh-Jairam M, Rodey G, et al. Lymphoid reconstitution after PBSC transplantation FACS-sorted CD34+ hematopoietic progenitors. Blood 1998;91:2588-2600.
37. Schulenburg A, Kalhs P, Worel N, Hocker P, Knobl P, Greinix HT. Immunologic recovery of patients given CD34-selected peripheral progenitor cell transplantation for malignant diseases. Bone Marrow Transplant 2000;25:223-224.
38. Saiz A, Blanco Y, Carreras E, et al. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology 2004;62:282-284.
39. Nash RA, Bowen JD, McSweeney PA, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003;102:2364-2372.
40. Foot ABM, Garin YJF, Ribaud P, Devergie A. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone marrow transplant 1994;14:241-245.
41. Pomeranz S, Naparstek E, Ashkenazi E, et al. Intracranial haematomas following bone marrow transplantation. J Neurol 1994;241:252-256.
42. Windrum P, Morris TC. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 2003;31:315.
43. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barré syndrome following allogenic bone marrow transplantation. Neurology 1997;49:1711-1714.